Marijuana Penny Stocks: Emerald Health and Khiron Life Sciences

penny stocks

Marijuana penny stocks are shining green this morning, as we kick off the last week of January. January has been an exceptional month for most cannabis stocks, as many have seen well above double-digital percentage gains in their stock shares. After a rough December, it seems investors are as confident as ever in the cannabis industry. 

Today, we’ll take a look at a pair of marijuana penny stocks that are dominating the TSXV. While the rest of the stock market is falling, cannabis stocks are rising. Let’s find out why!

Emerald Health Therapeutics Inc. (TSXV:EMH)

Emerald Health Therapeutics is a cannabis company that produces and sells medical cannabis in Canada. The company was formerly a pharmaceutical company that switched to cannabis in June of 2015. Emerald Health is headquartered in Victoria, British Columbia. 

This morning the marijuana penny stock company announced the expansions of Pure Sunfarms. Pure Sunfarms is Emerald’s 50-percent-owned joint venture that focuses on large-scale and low-cost quality cannabis. 

Capitalize off Cannabis
Sign up now to start receiving our investing insights for FREE!

 

Sunfarms just received its sixth amendment to its cultivation license and is now approved for a 1.1 million square feet greenhouse in Delta, British Columbia.

Dr. Avtar Dhillon, Executive Chairman and President of Emerald, said:

“We expect this facility to be in full production in the first half of 2019. With Emerald’s supply agreement for 40% of Pure Sunfarms’ 2019 production along with our Quebec and hemp operations, we are strongly positioned for quarter to quarter sales growth.”

According to Yahoo Finance, the marijuana penny stock is currently trading at $3.12 a share, up +$0.28 (+9.86%).

>> POTN Stock: Red Flags Abound for This Multi-Faceted Company

Khiron Life Sciences Corp. (TSXV:KHRN)

Khiron Life Sciences is among the top trading marijuana penny stocks on the TSXV today for volume and trades. The cannabis company is headquartered in Toronto, Ontario, and it develops cannabis products for medical purposes. The company was founded in 2017.

On Friday, Khiron announced it would acquire NettaGrowth. This acquisition gives Khiron access to sell its products in Uruguay and Brazil. This may be the reason why the company’s shares jumped up today.

According to Yahoo Finance, KHRN is currently trading at $2.09 a share, up +$0.295 (+16.43%).

 

Featured Image: Depositphotos © antpkr

If You Liked This Article Click To Share